AVEO Oncology
AVEO
#7456
Rank
โ‚ฌ0.46 B
Marketcap
13,41ย โ‚ฌ
Share price
0.00%
Change (1 day)
180.19%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚ฌ26.9 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚ฌ94.31 Million. In 2021 the company made an earning of -โ‚ฌ47.71 Million a decrease over its 2020 earnings that were of -โ‚ฌ31.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ26.9 Million-43.62%
2021 -โ‚ฌ47.71 Million49.9%
2020 -โ‚ฌ31.83 Million-479.04%
2019 โ‚ฌ8.39 M-276.17%
2018 -โ‚ฌ4.77 Million-91.79%
2017 -โ‚ฌ58.06 Million142.38%
2016 -โ‚ฌ23.96 Million78.51%
2015 -โ‚ฌ13.42 Million-71.55%
2014 -โ‚ฌ47.17 Million-50.72%
2013 -โ‚ฌ95.71 Million-4.88%
2012 -โ‚ฌ0.11 Billion-426.29%
2011 โ‚ฌ30.83 M-159.85%
2010 -โ‚ฌ51.53 Million35.33%
2009 -โ‚ฌ38.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ30.04 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ9.19 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ0.90 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.61 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.65 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚ฌ2.03 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA